Justin Meiklem

BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via its Newly Launched Botanical Synthesis CDMO Business Unit.   

Vancouver, British Columbia and Rehovot, Israel – February 26, 2024 – BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”), a biotechnology company pioneering the Botanical Synthesis process technology, has announced the official launch of its new Contract Development and Manufacturing Organization (CDMO) business unit. The Company is also announcing that […]

BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via its Newly Launched Botanical Synthesis CDMO Business Unit.    Read More »

BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

Vancouver, British Columbia and Rehovot, Israel – February 15, 2024 – BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”), a biotechnology company pioneering botanical synthesis, has engaged investor relations specialists MZ Group (MZ) to lead a strategic investor relations and financial communications program across all key markets. MZ will work

BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program Read More »

BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference

Vancouver, British Columbia and Rehovot, Israel – February 12, 2024 – BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”), a pioneer in Botanical Synthesis technology that grows Phyto-active compositions without growing the plant, announces its upcoming participation and title sponsorship of  the 2024 BIO CEO & Investor Conference, which will

BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference Read More »

ILAN SOBEL

BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update

Vancouver, British Columbia and Rehovot, Israel – January 8, 2024 – BioHarvest Sciences Inc., (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”), a pioneer in Botanical Synthesis technology that grows active Phyto-nutrient compositions without growing the plant, has issued a letter to shareholder partners  from Chief Executive Officer, Ilan Sobel. Dear Fellow Shareholder Partners,

BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update Read More »

img

BIOHARVEST SCIENCES INC. CLOSES FINAL TRANCHE OF OVERSUBSCRIBED $13.5M PRIVATE PLACEMENT

VANCOUVER, CANADA, and REHOVOT, ISRAEL, December 27, 2023 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) is pleased to announce that it has closed the second and final tranche of its non-brokered private placement of convertible notes (the “Notes”) previously announced on October 19 and October 20, 2023. In this tranche closed Friday

BIOHARVEST SCIENCES INC. CLOSES FINAL TRANCHE OF OVERSUBSCRIBED $13.5M PRIVATE PLACEMENT Read More »

BIOHARVEST SCIENCES ANNOUNCES MAJOR PRODUCT LAUNCH OF VINIA-BASED FUNCTIONAL COFFEES

Vancouver, British Columbia and Rehovot, Israel – December 13, 2023, BioHarvest Sciences Inc, (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) (“BioHarvest” or “the Company”) announces that it has created a new “functional” coffee product line featuring VINIA® Red Grape Superfood, its flagship nutraceutical product. Tens of thousands of subscribers take VINIA®  daily to improve blood flow,

BIOHARVEST SCIENCES ANNOUNCES MAJOR PRODUCT LAUNCH OF VINIA-BASED FUNCTIONAL COFFEES Read More »